Sign in
4

Changes in Ownership

PUMA BIOTECHNOLOGY, INC. Filed Acc 0001437749-24-004214

Chief Commercial Officer acquired 27,067 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ludwig Jeffrey Jerome Chief Commercial Officer 2024-02-12 Grant or award +27,067 127,037 D
Derivatives
Ludwig Jeffrey Jerome Chief Commercial Officer 2024-02-12 Grant or award · Stock Option (Right to Buy) +37,466 37,466 D
Loading xslF345X05/rdgdoc.xml…